Development and validation of a patient derived xenograft based preclinical platform for immuno-oncology drug development. (December 2016) - Oswald, E.; Grote, A.; Bug, D.; Löhr, A.; Lenhardt, D.; Niedermann, G.; Merhof, D.; Feuerhake, F.; Schüler, J.